Olcegepant

Olcegepant
Clinical data
ATC code None
Identifiers
CAS Number 204697-65-4
PubChem (CID) 6918509
ChemSpider 5293706
Chemical and physical data
Formula C38H47Br2N9O5
Molar mass 869.645 g/mol
3D model (Jmol) Interactive image

Olcegepant (INN) (code name BIBN-4096BS) is a calcitonin gene-related peptide receptor antagonist being studied as a potential treatment for migraines.[1]

A 2013 meta-analysis found olcegepant and telcagepant were effective and safe compared to placebo.[2]

See also

References

  1. Tfelt-Hansen, P; Olesen, J (Apr 2011). "Possible site of action of CGRP antagonists in migraine.". Cephalalgia : an international journal of headache. 31 (6): 748–50. doi:10.1177/0333102411398403. PMID 21383046.
  2. Yao, Gang; Yu, Tingmin; Han, Ximei; Mao, Xijing; Li, Bo (2013-04-05). "Therapeutic effects and safety of olcegepant and telcagepant for migraine: A meta-analysis". Neural Regeneration Research. 8 (10): 938–947. doi:10.3969/j.issn.1673-5374.2013.10.009. ISSN 1673-5374. PMC 4145922Freely accessible. PMID 25206386.


This article is issued from Wikipedia - version of the 7/10/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.